Keynotes

Wilson M. Compton, MD, MPE
Deputy Director, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services

Wilson M. Compton, MD, MPEWilson Compton devotes his considerable expertise to leading research on drug abuse and addiction throughout the world as Deputy Director of the National Institute on Drug Abuse of the National Institutes of Health. Most notably he led a national and international public health research project examining the extent of drug use and how to implement prevention and treatment programs. He was also at the helm of a joint study with the Food and Drug Administration on the impact of new U.S. tobacco regulations. He has authored over 150 articles and chapters and his extensive speaking engagements have included presentations to justices at the Federal Judicial Center explaining how the science of addiction may improve policy and practices related to persons with substance use disorders within the criminal justice system. Prior to his work at NIDA where he also served as the Director of Division of Epidemiology, Services and Prevention Research from 2002 until 2013, Dr. Compton taught psychiatry at Washington University in Saint Louis and was also Medical Director of Addiction Services at the Barnes-Jewish Hospital in Saint Louis.

Jay N. Giedd, MD
Professor and Chair, Child and Adolescent Psychiatry, University of California, San Diego

Jay N. Giedd, MDJay Giedd, a sought-after neuroscientist and researcher, has spent decades examining the developing adolescent brain. In an era marked by the ubiquitous use of personal electronic devices by teens, his long-term studies using brain imaging, genetics and psychological/behavioral assessments have produced groundbreaking insights into the impact digital technology habits have on the teenage brain. His work makes headlines and was highlighted on PBS’s Frontline (Inside the Teenage Brain) where he demystified influences on adolescent brain development like gender differences and the role of environmental versus genetic factors as well as the development of decision-making abilities. Currently a professor of psychiatry at University of California, San Diego, he was previously a professor at Johns Hopkins Bloomberg School of Public Health and Chief of the Section on Brain Imaging, Child Psychiatry Branch, National Institute of Mental Health.

 

Faculty

Carolyn Buppert, MSN, JD
Attorney, Law Office of Carolyn Buppert, PC

Donna Ecklesdafer, MSN, RN
Clinical Services Director – Nursing, PPG; ECT and TMS Clinic Manager, Pine Rest Christian Mental Health Services

Mary A. Gutierrez, PharmD, BCPP
Professor of Pharmacy Practice (Psychiatry), Chapman University School of Pharmacy

Wendy A. Henderson, PhD, MSN, CRNP, FAAN
Chief, Digestive Disorders Unit, Biobehavioral Branch, Division of Intramural Research, NINR, NIH, DHHS

Joseph M. Holshoe, PMHNP-BC
Commander, U.S. Public Health

Karen L. Houseknecht, PhD
Interim Dean, College of Pharmacy; Professor of Pharmacology, College of Osteopathic Medicine, University of New England

Robert Innis, MD, PhD
Chief, Section on PET Neuroimaging Sciences; Chief, Molecular Imaging Branch (MIB), National Institute of Mental Health, National Institutes of Health

Lorenzo Leggio, MD, PhD, MSc
Clinical Investigator, Chief, Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, NIAAA DICBR and NIDA IRP; Associate Director for Clinical Research, Medication Development Program, NIDA IRP, National Institutes of Health

Barbara J. Limandri, PhD, PMHCNS-BC
Psychiatric Mental Health Nurse Practitioner

Mary D. Moller, DNP, PhD, ARNP, PMHCNS-BC, CPRP, FAAN
Associate Professor, Pacific Lutheran University School of Nursing; Director of Psychiatric Services, Northwest Center for Integrated Health

Mary Ann Nihart, MA, APRN, PMHCNS-BC, PMHNP-BC
Associate Director Patient Care Services/Nurse Executive, San Francisco Veterans Affairs Health Care System; Associate Clinical Professor, University of California, San Francisco

AMERICAN PSYCHIATRIC NURSES ASSOCIATION and APNA-Logoare registered in the U.S. Patent and Trademark Office as trademarks of the American Psychiatric Nurses Association.
The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.